# SeQual Technologies, Inc. — Hazardous Materials Safety Interpretation

**Citation:** 10-0163  
**Type / status:** guidance / guidance  
**Agency:** Pipeline and Hazardous Materials Safety Administration  
**Effective:** Not stated  
**Published:** 2011-02-10

10-0163 response to SeQual Technologies, Inc. concerning 173.185, 175.10.

## Document text

<<<PAGE 1>>>

U.S. Department of Transportation 1200 New Jersey Ave. SE
Washington. D.C. 20590
Pipeline and Hazardous Materials
Safety Administration
FEB 1 02011
Ms. Pamela J. Jackson
Senior Director, Government and Military
SeQual Technologies, Inc.
11436 Sorrento Valley Road
San Diego, CA 92121
Reference No. 10-0163
Dear Ms. Jackson:
This is in response to your letter regarding the applicability of the Hazardous Materials
Regulations (HMR; 49 CFR Parts 100-180) to a device that your company calls the SAROSTM
Oxygen System.
You state that the SAROSTM Oxygen System is a device that separates oxygen from ambient air
through a process called Pressure Swing Absorption (PSA). Your product was developed in
cooperation with the US Army Medical Materiel Command to support the oxygen needs of
patients on a battlefield. This device consists of a lightweight, portable oxygen concentrator with
an integrated oxygen delivery valve for continuous flow or pulse delivery. The maximum
pressure of the oxygen exerted within the SAROSTM Oxygen System packaging is 23.7 psia
during normal operation at 20°C. The device can be powered by multiple power sources,
including AC or DC power, an AC adapter, rechargeable lithium ion batteries, and an auxiliary
DC power adapter for automotive applications. The battery pack consists of 16, 1.5 ampere-hour
lithium ion cells, and the total equivalent lithium content of the battery pack is 7.20 grams or 86
Watt-hours. The lithium ion cells and battery pack have been tested pursuant to the United
Nations Manual of Tests and Criteria and is packaged in a manner to prevent short circuits when
offered for transport or carried onboard passenger aircraft. You ask whether this device is
regulated as a hazardous material under the HMR.
Based on the information provided, the SAROSTM Oxygen System portable oxygen concentrator
is not currently subject to the HMR because: (1) the pressure of the oxygen in the device does
not exceed 280 kPa absolute (40.6 psia) at 20°C (68 oF); (2) the lithium ion battery used to
operate the device is excepted from the HMR under § 172.102(c)(1), Special provision 188; (3)
the portable oxygen concentrator contains no other materials subject to the HMR; and (4) the
battery pack is packaged in a manner to preclude it from creating sparks or generating a
dangerous quantity of heat (for example, by the effective insulation of exposed terminals).

<<<PAGE 2>>>

Although the exception in § 175.1O(a)(17) would apply to a passenger carrying a SAROSTM
Oxygen System as described above, the approval of the Federal Aviation Administration (FAA)
is required before it may be used by a passenger onboard an aircraft. The FAA published a final
rule on July 12, 2005 (70 FR 40155; copy enclosed) regarding these devices. For further
assistance, you may contact Mr. Dave Catey, Aviation Safety Inspector for the FAA Air Carrier
Operations Branch (AFS-220) by phone at (202)-267-3732 or email atdavid.catey@faa.gov.In
addition, even with FAA approval, an air carrier ultimately determines what mayor may not be
carried on its aircraft. We suggest that you contact the airlines to ensure that the SAROSTM
Oxygen System may be carried.
I trust this satisfies your inquiry. Please contact us if we can be of further assistance.
Sincerely,
T. Glenn Foster
Chief, Regulatory Review and Reinvention Branch
Standards and Rulemaking Division

<<<PAGE 3>>>

s+eVeY16
~ ( 1 ~. I 0 (aX, 1)
Air The Smart Choice.
~SEQLJAl
SeQual Technologies Inc.
)0-DI(05 11436 Sorrento Valley Road
San Diego, CA 92121
Phone 858.202.3100
Fax 858.558.1915
www.sequaLcom
July 22, 2010
Office of Hazardous Materials Standards
Pipeline and Hazardous Materials Safety Administration
U.S. Department of Transportation
1200 New Jersey Avenue, SE
Washington, D.C. 20590
Re: Classification of SeQual Technologies' Lithium ion Battery and SAROSTM Oxygen System
To Whom It May Concern:
I am writing to request written confirmation from the Pipeline and Hazardous Materials Safety
Administration (pHMSA) that the lithium ion battery used in our new SAROSTM Oxygen System is
not subject to the U.S. hazardous materials regulations (HMR) pursuant to Special Provision 188 and
may be carried onboard passenger aircraft pursuant to 49 CFR § 175.10(a)(17).
Background
The SeQual SAROS Oxygen System is a device that separates oxygen from ambient air through a
process called Pressure Swing Adsorption (PSA). The product was developed in cooperation with the
US Army Medical Materiel Command to support the oxygen needs of the patients on the battlefield.
The SAROS provides a solution to address both stationary and portable requirements for oxygen
patients needing up to 3 LPM full flow operation and up to 96 ml flow in a pulse mode operation. It
consists of a lightweight, portable oxygen concentrator with an integrated oxygen delivery valve for
continuous flow or pulse delivery and is capable of being operated directly from an AC or DC power
source or from rechargeable lithium ion batteries. It can be recharged and/or powered by a separate
AC Power Adapter or where standard AC line power is available. A 24 Volt DC Cable or the 12 Volt
DC cable accessories allow power to be provided by a DC auxiliary power outlet, such as in a motor
vehicle during transportation. Changeable and rechargeable battery packs are available to provide a
range of ambulatory operational time.
The SAROS Oxygen System achieves its performance through SeQual's patented Advanced
Technology Fractionator (ATF®) technology arid patented variable speed compressor and compressor
drive, advanced molecular'sieve materials and rechargeable batteries. This system will expand an
oxygen patient's ability to travel via aircraft and improve the patient's quality of life.

<<<PAGE 4>>>

~SEQUAL
The Smart Choice.
Class 2, Division 2.2 Gas - 49 CFR 173.115
The maximum pressure of the oxygen exerted within the SAROS Oxygen System packaging currently
is 23.7 psia during normal operation at 20° C. This is substantially less than the 40.6 psia at 20° C
referenced in 49 CFR 173.115(b)(1) for defining a Division 2.2 gas. Therefore, it is our opinion that
the oxygen exerted within the SAROS Oxygen System is not a Division 2.2 gas and thus is not subject
to the U.S. HMR.
Lithium ion Batteries used in SAROS Oxygen System
The SAROS Oxygen System is powered by a lithium ion battery pack that consists of 16, 1.5 amperehour
lithium ion cells. Therefore, the battery contains an aggregate equivalent lithium content of 7.20
grams (or 86 Watt-hours). The cells and battery have been tested pursuant to the requirements of the
UN Manual of Tests and Criteria.
It is our opinion that the lithium ion battery is not subject to the HMR pursuant to Special Provision
188 because the cells contain not more than 1.5 grams of equivalent lithium content, the battery
contains not more than 8 grams of equivalent lithium content, the cells and battery have been tested in
accordance with the UN Manual ofTests and Criteria and the battery and SAROS Oxygen System will
be packed pursuant to the requirements of Special Provision 188 when offered for transport. The
battery also meets the exception found in 49 CFR 175.1 O(a) (17) for passengers and crew members.
This provision is generally consistent with one found in the ICAO Technical Instructions that
authorizes consumer electronic devices containing lithium ion batteries with up to 100 Watt-hours to
be carried onboard passenger aircraft.
* * * *
I trust the information contained herein is sufficient for PHMSA to provide a written determination
that the SAROSTM Oxygen System and lithium ion battery used to power it are not subject to the U.S.
HMR pursuant to Special Provision 188 and they meet the exception found in 49 CFR 175.l0(a)(17)
for passengers and crew members. Should you need additional information or have any questions
regarding our product, please do not hesitate to call me at the contact information below.
Respectfully,
.~rM1f1...0ffUl':' (11,Pamela
J. Jackson
Senior Director, Government and Military
SeQual Technologies Inc.
11436 Sorrento Valley Road
San Diego, CA 92121
Phone: 858-202-3144
Cell: 760-805-9000
Email: pjackson@segua1.com
Page 2 of2

## Provenance

- Official: Yes
- Source: <https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretations/2010/100163.pdf>
- Source ID: `phmsa`
- SHA-256: `b95ed9d92c1f6a699fdecc8173d9cc0907a6f2394adb88b8593771a3bc37fd6c`
- Retrieved: 2026-08-20T00:59:31.977Z
- Exported: 2026-08-23T13:51:49.373Z
- Document slug: `phmsa-interpretation-10-0163`

### Source metadata

```json
{
  "materialSubtype": "interpretation",
  "interpretationArea": "hazardous_materials",
  "representation": "full_text_from_official_pdf",
  "companies": [
    "SeQual Technologies, Inc."
  ],
  "individuals": [
    "Ms. Pamela J. Jackson"
  ],
  "refIds": [
    "10-0163"
  ],
  "catalogDates": [
    "2011-02-10"
  ],
  "catalogParts": [
    173,
    175
  ],
  "catalogRowCount": 2,
  "sourceRecordUrls": [
    "https://www.phmsa.dot.gov/node/53096"
  ],
  "linkedAttachmentUrls": [],
  "unavailableResponseUrls": [],
  "duplicateRepresentationUrls": [],
  "citedSections": [
    "173.185",
    "175.10",
    "175.10(a)(17)",
    "40.6",
    "172.102(c)(1)",
    "175.1O(a)(17)",
    "173.115",
    "175.1"
  ],
  "catalogPageUrls": [
    "https://www.phmsa.dot.gov/regulations/title49/section/173185",
    "https://www.phmsa.dot.gov/regulations/title49/section/17510"
  ],
  "pdfUrls": [
    "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretations/2010/100163.pdf"
  ],
  "representations": [
    {
      "viewUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretations/2010/100163.pdf",
      "detailUrl": null,
      "detailHtmlPath": null,
      "pdfUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretations/2010/100163.pdf",
      "pdfArtifactPath": "data/sources/phmsa-interpretations/10-0163-4fc3699e73.pdf",
      "pdfArtifactSha256": "d2543e47f3bb585925dcc6f83017161c35c02816c862117fc96137b3cbb03179",
      "extractedTextPath": "data/sources/phmsa-interpretations/10-0163-4fc3699e73.v2.txt",
      "extractedTextSha256": "4832a6a0d0ae88ae98ea5dc1759732197c913c8801edfa889a9e5f3584c3260a",
      "pageCount": 4,
      "extractionVersion": 2
    }
  ],
  "caveat": "Interpretations apply regulations to the facts presented and do not create independently enforceable requirements.",
  "jurisdiction": "US"
}
```
